Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin
Go back to Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 3.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $9.58 | |||
| Open | $3.12 | 52 Week Low | $2.34 | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $3.12 | EPS | $-0.34 | |||
| Volume | 9,653,099 | |||||
